New Allergy Medication Coming to the US - Xyzal

by Kathi MacNaughton Health Professional

If you haven't gotten the relief you want from your current allergy medicine, there's a new drug on the market that might be worth talking with your doctor about.

It's called Xyzal
® (generic name: levocetirizine dihydrochloride) and it's an antihistamine already used in more than 80 countries worldwide to treat both indoor and outdoor allergies, as well as a skin condition called idiopathic urticaria.

The medication is being marketed in the US by drugmakers UCB and sanofi-aventis. Studies have shown that Xyzal significantly reduces common allergy symptoms such as sneezing, itchy nose, runny nose, and itchy eyes.

It's taken once daily and would be equivalent to other once-daily antihistamines such as Allegra, Claritin, and Zyrtec.

In my opinion, finding relief for allergies is somewhat of a trial and error situation. And what works well for one person doesn't always do the same for someone else. I know that I've always gotten the best relief from Allegra. But I know other people who swear by Claritin or Zyrtec.

According to an Allergy and Asthma Foundation of America survey, 60 percent of people taking a prescription antihistamine were interested in finding a different treatment for their allergies.

So, the bottom line is that if like the survey respondents you're not happy with your allergy treatment, it might be time to ask your doctor if Xyzal might be right for you.

Read Kathi's other articles:

Back to School: How to protect your child from allergy triggers

Will peanut allergies be a thing of the past?

Allergies in the sky: The controversy of banning food on airplanes

Kathi  MacNaughton
Meet Our Writer
Kathi MacNaughton

Kathi is an experienced consumer health education writer, with a prior career in nursing that spanned more than 30 years — much of it in the field of home health care. Over the past 15 years, she's been an avid contributor for a number of consumer health websites, specializing in asthma, allergy, and COPD. She writes not only as a healthcare professional, but also as a lifelong sufferer of severe allergies and mild asthma, and as a caregiver for her mother with COPD.